Ultime notizie per Health Catalyst (NASDAQ:HCAT) Azioni

HEALTH CATALYST INC

Health Catalyst

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Health Catalyst Inc

Goldman Sachs analyst David Roman initiates coverage on Omada Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMDA#NASDAQ">OMDA</a>) with a Buy rating and announces Price Target of $29.

News

Price Target

Initiation

Analyst Ratings

OMDA

Goldman Sachs Initiates Coverage On Omada Health with Buy Rating, Announces Price Target of $29

Wells Fargo analyst James Feldman maintains RLJ Lodging (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RLJ#NYSE">RLJ</a>) with a Underweight and raises the price target from $6 to $7.

Wells Fargo Maintains Underweight on RLJ Lodging, Raises Price Target to $7

WIIM

NIVF

NIVF stock has given up its prior gain. Newgenlvf Group shares were trading higher after the company announced that its subsidiary secured strategic land in the UAE for its Blockchain initiative.

Trading Ideas

RedCloud Holdings Shares Resume Trade

Wells Fargo analyst James Feldman maintains Pebblebrook Hotel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEB#NYSE">PEB</a>) with a Equal-Weight and raises the price target from $9 to $10.

Wells Fargo Maintains Equal-Weight on Pebblebrook Hotel, Raises Price Target to $10

YAAS

Youxin Technology Shares Halted On Circuit Breaker To The Downside, Stock Now Down -59.2%

Goldman Sachs analyst Jerry Revich upgrades Oshkosh (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSK#NYSE">OSK</a>) from Neutral to Buy and raises the price target from $124 to $131.

Upgrades

Goldman Sachs Upgrades Oshkosh to Buy, Raises Price Target to $131

U.S. stocks were mixed, with the Dow Jones index gaining over 250 points on Tuesday.
Shares of Mesoblast Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>) rose sharply during Tuesday's session after the company announced alignment with the U.S. Food and Drug Administration (FDA) on items required for filing a Biologics License Application (BLA) for Revascor (rexlemestrocel-L) for ischemic heart failure with reduced ejection <a href="https://www.benzinga.com/quote/MESO">fraction (HFrEF) and inflammation</a>.
Mesoblast shares jumped 11.8% to $12.18 on Tuesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Atai Life Sciences N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAI#NASDAQ">ATAI</a>) shares jumped 30.3% to $2.8549 after the company announced it raised $50 million via a private placement.</li>
<li>McEwen Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MUX#NYSE">MUX</a>) gained 13.6% to $10.91.</li>
<li>Bloomin&#8217; Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>) gained 11.9% to $9.63.</li>
<li>Citius Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTOR#NASDAQ">CTOR</a>) gained 11% to $4.8300.</li>
<li>Melco Resorts &amp; Entertainment Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLCO#NASDAQ">MLCO</a>) rose 10.8% to $8.02 after JP Morgan upgraded the stock from Neutral to Overweight and raised its price target from $7.2 to $9.5.</li>
<li>Studio City International Holdings Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSC#NYSE">MSC</a>) gained 10.7% to $3.5159.</li>
<li>IREN Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) gained 9.3% to $15.93. IREN named Anthony Lewis as Chief Capital Officer to lead capital markets strategy.</li>
<li>Wynn Resorts, Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>) rose 9.1% to $102.24. Shares of casino stocks trading higher after Macau June casino revenue reportedly rose.</li>
<li>Las Vegas Sands Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVS#NYSE">LVS</a>) gained 7.4% to $46.74.</li>
<li>Advance Auto Parts, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAP#NYSE">AAP</a>) rose 7% to $49.79.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/07/46190223/top-3-tech-stocks-that-could-lead-to-your-biggest-gains-in-july">Top 3 Tech Stocks That Could Lead To Your Biggest Gains In July</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

ATAI

BLMN

CTOR

IREN

MESO

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

WYNN

Mesoblast, Atai Life Sciences, Melco Resorts & Entertainment And Other Big Stocks Moving Higher On Tuesday

Wells Fargo analyst James Feldman maintains Park Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PK#NYSE">PK</a>) with a Equal-Weight and raises the price target from $10 to $11.

Wells Fargo Maintains Equal-Weight on Park Hotels & Resorts, Raises Price Target to $11

Wells Fargo analyst James Feldman maintains Host Hotels &amp; Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HST#NASDAQ">HST</a>) with a Overweight and raises the price target from $16 to $18.

Wells Fargo Maintains Overweight on Host Hotels & Resorts, Raises Price Target to $18

<a href="https://www.thetimes.com/article/12c7c719-a6b2-443c-b28c-3e1fba76b64d" title="https://www.thetimes.com/article/12c7c719-a6b2-443c-b28c-3e1fba76b64d">https://www.thetimes.com/article/12c7c719-a6b2-443c-b28c-3e1fba76b64d</a>

Global

'AstraZeneca CEO wants to move Britain's most valuable company to US' - The Times

<a href="https://www.bloomberg.com/news/articles/2025-07-01/e-commerce-firm-jumia-said-to-draw-takeover-interest-from-axian">https://www.bloomberg.com/news/articles/2025-07-01/e-commerce-firm-jumia-said-to-draw-takeover-interest-from-axian</a>

General

JMIA

'E-Commerce Firm Jumia Draws Takeover Interest From Axian'- Bloomberg

CCIIU

Trading Halt: Halt status updated at 10:35:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

Wells Fargo analyst James Feldman maintains Diamondrock Hospitality (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRH#NYSE">DRH</a>) with a Equal-Weight and raises the price target from $7.75 to $8.25.

Wells Fargo Maintains Equal-Weight on Diamondrock Hospitality, Raises Price Target to $8.25

<a href="https://www.youtube.com/watch?v=L6rcfh4Q-rk">https://www.youtube.com/watch?v=L6rcfh4Q-rk</a>

Macro Notification

Politics

Economics

Fed Chair Powell Does Not Comment On Whether He Will Stay On As Governor After May 2026; Says I Do Fully Support Bowman's Proposal On Leverage Ratio

Crexendo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CXDO#NASDAQ">CXDO</a>) appears poised to gain share in the wholesale UCaaS (United Communications as a Service) market, according to Needham.
The Crexendo Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/602e465f5864de0001ada5b0/joshua-reilly">Analyst Joshua Reilly</a> initiated coverage with a Buy rating and price target of $8.
The Crexendo Thesis: The cloud communications company has an open platform strategy with pre-packaged features that have the "right balance of configuration" for both retail and wholesale customer wins. Reilly credits this for driving market share gains since the NetSapiens acquisition in 2021.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
The open platform has more than 240 integrations, which allows Crexendo to maintain a "disruptive pricing model" and focus on innovation, while its competitors struggle to maintain their customer bases, he added.
"In addition to winning net new licensee opportunities, we believe Crexendo intends to acquire and consolidate licensees at an intentional pace over time," the analyst wrote.
The company's non-GAAP operating margin is likely to expand in 2025 and beyond due to the ongoing growth in both telecom services and software solutions, he further stated.
Price Action: Shares of Crexendo had risen by 4.78% to $6.36 at the time of publication on Tuesday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/24/06/39400336/uber-enters-into-partnership-with-discount-grocer-save-a-lot">UBER Enters Into Partnership With Discount Grocer Save A Lot</a></li>
</ul>
Image: Shutterstock

Analyst Color

Movers

CXDO

Crexendo's Open Strategy Pays Off, Analyst Praises 'Disruptive Pricing Model'

Macro Economic Events

Econ #s

Dallas Fed Services Revenues For June -4.1 Vs -4.7 Prior

Texas Services Sector Outlook For June -4.4 Vs -10.1 Prior

DDC stock has given up its prior gain. DDC Enterprise shares were trading higher after the company announced the closing of its $528 million capital financing round with Anson Funds to advance its Bitcoin treasury strategy.

Wells Fargo analyst Michael Sison maintains RPM Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>) with a Overweight and raises the price target from $116 to $131.

Wells Fargo Maintains Overweight on RPM Intl, Raises Price Target to $131

Earnings

Press Releases

Health Catalyst Reports Fourth Quarter and Year End 2024 Results

Contracts

Signature Healthcare to Enhance Analytics by Leveraging Health Catalyst Ignite™

Health Catalyst Announces ~$5 Million Stock Repurchase

Ardent Health Appoints Robert DeMichiei to Board of Directors

Health Catalyst Releases Data and Analytics Solution Designed for Community, Regional, and Specialty Health Systems: Health Catalyst Ignite Spark™

Health Catalyst to Announce First Quarter 2025 Operating Results and Host Conference Call on Wednesday, May 7, 2025

Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations

Health Catalyst Reports First Quarter 2025 Results

Health Catalyst to Participate in Upcoming Investor Conferences

Accelerating Measurable Improvement Through Actionable Insights: Health Catalyst Announces the Release of 10 AI-Integrated Data Toolkits on Databricks Marketplace

Comments

Health Catalyst

Notizie

Ultime notizie per Health Catalyst (NASDAQ:HCAT) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO